Project Grant R21EY037454
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$417K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Houston, TX 77204, USA
Similar Awards
The National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), awarded a $300,001 Project Grant to Kineolabs, Inc. in Billerica, MA. The objective of this 1-year grant, which runs from July 1, 2025 to June 30, 2026, is to develop a portable, low-cost line-scan swept-source optical coherence tomography (LS-SS-OCT) imaging system. This system is intended for early detection and monitoring of age-related macular degeneration (AMD), diabetic retinopathy, and other eye...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $237,996 to investigate groundbreaking approaches for in-vivo high-resolution imaging of fine corneal structures. The award aims to develop a speckle illumination holographic imaging system with polarization and phase-sensitive detection, enabling wide field-of-view and 3D imaging capabilities to overcome limitations of current corneal imaging techniques. If successful,...
The National Eye Institute (NEI), part of the National Institutes of Health, awarded a $331,131 Project Grant under the Vision Research program (CFDA 93.867) to Physical Sciences Inc. (PSI) to develop and validate a high-resolution retinal imaging system with light flicker capabilities. This system aims to enable objective characterization of the photoreceptor response to light and quantify differences between normal and diseased eyes, particularly for patients with diabetic retinopathy. PSI,...
The National Eye Institute (NEI), through its Vision Research federal grant program (CFDA 93.867), awarded a $679,159 Project Grant to The Schepens Eye Research Institute, Inc. in Boston, Massachusetts. The grant, awarded on May 1, 2025, supports research aimed at understanding how aging and elevated intraocular pressure (IOP) contribute to the development of glaucoma and impact retinal ganglion cells (RGCs). The research project will investigate the transcriptomic changes in RGCs due to aging...
The National Eye Institute (NEI) awarded a $256,296 Project Grant (CFDA 93.867 - Vision Research) to The General Hospital Corporation (Massachusetts General Hospital) to develop new "Auto-Sensing, Instantaneous Adaptive Ranging Optical Coherence Tomography (OCTA)" technology. This technology aims to expand the imaging depth range of OCTA systems, enabling improved visualization of the critical peripheral retinal microvasculature. The project will leverage advances in integrated...
This Project Grant award, valued at $728,165 and provided by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867), supports research into the role of orexins in regulating intraocular pressure (IOP) as it relates to glaucoma. The key objectives are to: Examine the role of the brainstem raphe pallidus region in mediating DMH/PEF-induced IOP elevations by measuring the impact of local orexin receptor antagonists. Assess the degree to which orexin...
The National Eye Institute (NEI) awarded a $179,964 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of California, Irvine (UCI) with a project period from March 1, 2025 to July 10, 2029. The project aims to develop innovative deep learning-based retinal optical coherence tomography (OCT) biomarkers to improve the diagnosis and management of optic neuropathies, a group of eye diseases that primarily target the optic nerve and frequently result in...
This federal Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) provides $617,201 in funding to Emory University to conduct research aimed at improving the understanding and management of glaucoma, a leading cause of blindness. The key research objectives are to: 1) Map the 3D paths of optic nerve axons using optical coherence tomography (OCT) imaging; 2) Leverage AI to assess whether axonal deformations could serve as diagnostic and prognostic biomarkers for...
This Project Grant award from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) will fund the development of a new wide-field visible-light optical coherence tomography (WF-VIS-OCT) device to evaluate the oxygen-induced retinopathy (OIR) model in rats. The $623,090 award, effective September 1, 2024, will support the Oregon Health & Science University in three main efforts: 1) developing the WF-VIS-OCT system with 5-mm transverse resolution over a...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), supports research to enhance stem cell restoration of intraocular pressure (IOP) homeostasis in glaucoma through senolytic treatments. The $234,000 award to Oregon Health & Science University aims to use senolytics and senoreverters to restore TM cell IOP homeostatic function in glaucomatous tissue, with or without stem cell transplantation. This research has the...